Search research articles
Contact Us
Filters
Showing results (161-170 of 180) with videos related to
Page
of 18
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
August 3, 2019
SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D<sub>2</sub> Receptor Mechanism of Action
Nina Dedic, Philip G Jones, Seth C Hopkins, et al.
European Journal of Medicinal Chemistry
|
May 19, 2026
Discovery of a highly selective and potent kappa opioid receptor agonist from N-cyclopropylmethyl-7α-piperazinyl -6,14-endoethano-tetrahydronorthebaines
Shaoliang Duan, Shuyang Hu, Yun Fang, et al.
Journal of Medicinal Chemistry
|
August 13, 2021
Discovery of an <i>M</i>-Substituted <i>N</i>-Cyclopropylmethyl-7α-phenyl-6,14-endoethanotetrahydronorthebaine as a Selective, Potent, and Orally Active κ-Opioid Receptor Agonist with an Improved Central Nervous System Safety Profile
Qian He, Yuanyuan Wei, Xiao Liu, et al.
European Journal of Medicinal Chemistry
|
October 15, 2018
Discovery, cocrystallization and biological evaluation of novel piperidine derivatives as high affinity Ls-AChBP ligands possessing α7 nAChR activities
Xicheng Yang, Jian Shen, Lulu Jiang, et al.
Autophagy
|
June 19, 2019
SNX10 (sorting nexin 10) inhibits colorectal cancer initiation and progression by controlling autophagic degradation of SRC
Sulin Zhang, Zhiwen Yang, Weilian Bao, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 12, 2011
Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor
Liming Shao, Michael C Hewitt, Fengjiang Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 12, 2011
Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor
Liming Shao, Michael C Hewitt, Fengjiang Wang, et al.
Journal of Medicinal Chemistry
|
July 12, 2011
Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues
Liming Shao, Michael C Hewitt, Scott C Malcolm, et al.
Journal of Medicinal Chemistry
|
July 28, 2022
<b>SLL-627</b> Is a Highly Selective and Potent κ Opioid Receptor (KOR) Agonist with an Unexpected Nonreduction in Locomotor Activity
Linghui Kong, Xuelian Shu, Siyuan Tang, et al.
European Journal of Medicinal Chemistry
|
January 22, 2026
Structure-activity relationship of N-cyclopropylmethyl-7α-(m-methylaminophenyl)-6,14-endoethano-northebaine derivatives as G-protein-biased KOR-selective agonists
Siyuan Tang, Jiangwen Gui, Yingjie Lan, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 180) with videos related to
Sort By:
Page
of 18
The Journal of Pharmacology and Experimental Therapeutics
|
August 3, 2019
SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D<sub>2</sub> Receptor Mechanism of Action
Nina Dedic, Philip G Jones, Seth C Hopkins, et al.
European Journal of Medicinal Chemistry
|
May 19, 2026
Discovery of a highly selective and potent kappa opioid receptor agonist from N-cyclopropylmethyl-7α-piperazinyl -6,14-endoethano-tetrahydronorthebaines
Shaoliang Duan, Shuyang Hu, Yun Fang, et al.
Journal of Medicinal Chemistry
|
August 13, 2021
Discovery of an <i>M</i>-Substituted <i>N</i>-Cyclopropylmethyl-7α-phenyl-6,14-endoethanotetrahydronorthebaine as a Selective, Potent, and Orally Active κ-Opioid Receptor Agonist with an Improved Central Nervous System Safety Profile
Qian He, Yuanyuan Wei, Xiao Liu, et al.
European Journal of Medicinal Chemistry
|
October 15, 2018
Discovery, cocrystallization and biological evaluation of novel piperidine derivatives as high affinity Ls-AChBP ligands possessing α7 nAChR activities
Xicheng Yang, Jian Shen, Lulu Jiang, et al.
Autophagy
|
June 19, 2019
SNX10 (sorting nexin 10) inhibits colorectal cancer initiation and progression by controlling autophagic degradation of SRC
Sulin Zhang, Zhiwen Yang, Weilian Bao, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 12, 2011
Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor
Liming Shao, Michael C Hewitt, Fengjiang Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 12, 2011
Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor
Liming Shao, Michael C Hewitt, Fengjiang Wang, et al.
Journal of Medicinal Chemistry
|
July 12, 2011
Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues
Liming Shao, Michael C Hewitt, Scott C Malcolm, et al.
Journal of Medicinal Chemistry
|
July 28, 2022
<b>SLL-627</b> Is a Highly Selective and Potent κ Opioid Receptor (KOR) Agonist with an Unexpected Nonreduction in Locomotor Activity
Linghui Kong, Xuelian Shu, Siyuan Tang, et al.
European Journal of Medicinal Chemistry
|
January 22, 2026
Structure-activity relationship of N-cyclopropylmethyl-7α-(m-methylaminophenyl)-6,14-endoethano-northebaine derivatives as G-protein-biased KOR-selective agonists
Siyuan Tang, Jiangwen Gui, Yingjie Lan, et al.
Page
of 18